AgingResearch.News
Frontiers in Cardiovascular Medicine

Abnormal "Escherichia Shigella-EAT-LAAD" axis in HFrEF patients with AF and the regulatory effect of SGLT2 inhibitors

By Jia-Ming Han, Fang-Yi Zhu, Xiao-hu Niu, Show 3 more authorsYulan Ma
Figure 1. Comparison of EATV and EATVI between HFrEF_NAF patients and HFrEF_AF patients before and after SGLT2i treatment.
Open the figure at full size
Figure 1. Comparison of EATV and EATVI between HFrEF_NAF patients and HFrEF_AF patients before and after SGLT2i treatment.Comparison of EATV and EATVI between HFrEF_NAF patients and HFrEF_AF patients before and after SGLT2i treatment.Han et al.
Non-randomised trial in peopleInterventions

12 months, registered ChiCTR2400088128, declared no competing interests

Paper

The paper

Jia-Ming Han, Fang-Yi Zhu, Xiao-hu Niu, Show 3 more authorsYulan Ma

Qinghai University; Qinghai Cardio-Cerebrovascular Specialty Hospital

Frontiers in Cardiovascular Medicine, 21 Aug 2026

doi.org/10.3389/fcvm.2026.1872678PubMed 42698822

More on Atrial fibrillation